EV-to-EBIT is calculated as Enterprise Value divided by its EBIT. As of today, Cronos Group's Enterprise Value is $87.23 Mil.
Cronos Group's EBIT for the trailing twelve months (TTM) ended in Dec. 2023 was $-81.14 Mil. Therefore, Cronos Group's EV-to-EBIT for today is -1.08.
The historical rank and industry rank for Cronos Group's EV-to-EBIT or its related term are showing as below:
CRON'
s EV-to-EBIT Range Over the Past 10 Years
Min: -21354.77 Med: -3.11 Max: 24.27
Current: -1.08
During the past 10 years, the highest EV-to-EBIT of Cronos Group was 24.27. The lowest was -21354.77. And the median was -3.11.
CRON's EV-to-EBIT is ranked worse than 100% of 670
companies
in the Drug Manufacturers industry
Industry Median: 17.115
vs CRON: -1.08
Joel Greenblatt calls the inversion of this ratio Earnings Yield (Joel Greenblatt) %. Cronos Group's Enterprise Value for the quarter that ended in Dec. 2023 was $-65.51 Mil.
Cronos Group's EBIT for the trailing twelve months (TTM) ended in Dec. 2023 was $-81.14 Mil. Cronos Group's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Dec. 2023 was 123.86%.
Cronos Group EV-to-EBIT Historical Data
The historical data trend for Cronos Group's EV-to-EBIT can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Competitive Comparison of Cronos Group's EV-to-EBIT
For the Drug Manufacturers - Specialty & Generic subindustry, Cronos Group's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Cronos Group's EV-to-EBIT Distribution in the Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Cronos Group's EV-to-EBIT distribution charts can be found below:
* The bar in red indicates where Cronos Group's EV-to-EBIT falls into.
Cronos Group EV-to-EBIT Calculation
Cronos Group's EV-to-EBIT for today is calculated as:
Cronos Group's current Enterprise Value is $87.23 Mil.
Cronos Group's EBIT for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $-81.14 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Cronos Group (NAS:CRON) EV-to-EBIT Explanation
This is a more accurate valuation of companies' operation because it considers the debt and cash on its balance sheet, and non-operating items such as interest payment, tax, and one-time items are not included in the Operating Income.
Cronos Group's Enterprise Value for the quarter that ended in Dec. 2023 was $-65.51 Mil.
Cronos Group's EBIT for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $-81.14 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Cronos Group EV-to-EBIT Related Terms
Thank you for viewing the detailed overview of Cronos Group's EV-to-EBIT provided by GuruFocus.com. Please click on the following links to see related term pages.
Cronos Group, headquartered in Toronto, Canada cultivates and sells medicinal and recreational cannabis through its medicinal brand, Peace Naturals, and its two recreational brands, Cove and Spinach. Although it primarily operates in Canada, Cronos exports medical cannabis primarily to Israel. In the U.S. the company has an option to acquire 10.5% of U.S. multistate operator PharmaCann upon easing of federal prohibition.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
CRON has been successfully added to your 